WG
EGRX

Winton Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Winton Group’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,234
Closed -$471K – 963
2023
Q2 		$471K Buy
24,234
+877
+4% +$20.8K 0.04% 348
2023
Q1 		$663K Buy
23,357
+3,584
+18% +$106K 0.04% 589
2022
Q4 		$578K Sell
19,773
-11,252
-36% -$358K 0.04% 587
2022
Q3 		$820K Buy
31,025
+9,471
+44% +$348K 0.05% 476
2022
Q2 		$958K Buy
21,554
+5,224
+32% +$240K 0.05% 499
2022
Q1 		$808K Buy
16,330
+6,198
+61% +$297K 0.04% 538
2021
Q4 		$516K Sell
10,132
-10,360
-51% -$537K 0.03% 670
2021
Q3 		$1.14M Sell
20,492
-3,968
-16% -$195K 0.06% 435
2021
Q2 		$1.05M Sell
24,460
-2,377
-9% -$98.1K 0.06% 507
2021
Q1 		$1.12M Buy
26,837
+9,805
+58% +$455K 0.06% 397
2020
Q4 		$793K Sell
17,032
-12,412
-42% -$581K 0.06% 534
2020
Q3 		$1.25M Sell
29,444
-88,299
-75% -$3.86M 0.04% 717
2020
Q2 		$5.65M Sell
117,743
-23,628
-17% -$1.18M 0.15% 170
2020
Q1 		$6.5M Sell
141,371
-12,853
-8% -$645K 0.17% 160
2019
Q4 		$9.27M Buy
154,224
+147,848
+2,319% +$8.82M 0.13% 259
2019
Q3 		$361K Buy
6,376
+730
+13% +$41.1K ﹤0.01% 1204
2019
Q2 		$314K Buy
+5,646
New +$294K 0.01% 874
2019
Q1 		– Sell
-237,080
Closed -$9.55M – 1208
2018
Q4 		$9.55M Buy
+237,080
New +$12.2M 0.21% 213

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Winton Group's EGRX Position: Q3 2023 in Review

Winton Group sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 24,234 shares — an estimated $471K sold.

Winton Group first reported a position in EGRX in Q4 2018 and held it in 18 quarters. The position peaked at $9.55M in Q4 2018. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

  • Winton Group reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Winton Group sold 24,234 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $471K.
  • Winton Group first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2018 and held it in 18 quarters.
  • Winton Group's Eagle Pharmaceuticals, Inc. position peaked at $9.55M in Q4 2018.
  • 107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on Winton Group's 13F filing for Q3 2023, filed 13 Nov 2023.